Bumper Offer - Urjas oil Just @ Rs. 1
Clobetamos is a prescription drug, available for use as Gel. Psoriasis, Eczema, Dermatitis are some of its major therapeutic uses. Other than this, Clobetamos has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Clobetamos is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Clobetamos as well, which are listed below. These side effects of Clobetamos are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Clobetamos's effect is Moderate during pregnancy and Mild for lactating mothers. It is important to know if Clobetamos has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Clobetamos related warnings section.
Other contraindications of Clobetamos have been discussed in the sections ahead.
Drug interactions for Clobetamos have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Clobetamos is considered safe while driving, and is addictive.
Clobetamos is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Clobetamos is used -
Moderate
Mild
Is the use of Clobetamos safe for pregnant women?
Pregnant women may experience moderate side effects from Clobetamos. It is best to stop taking Clobetamos immediately and inform your doctor if you notice any discomfort.
Is the use of Clobetamos safe during breastfeeding?
Clobetamos has been seen to have minimal side effects on breastfeeding women.
What is the effect of Clobetamos on the Kidneys?
There are no side effects of Clobetamos on the kidneys.
What is the effect of Clobetamos on the Liver?
Using Clobetamos does not have any harmful effects on the liver.
What is the effect of Clobetamos on the Heart?
There are no any side effects of Clobetamos for the heart.
Clobetamos should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clobetamos unless your doctor advises you to do so -
Is this Clobetamos habit forming or addictive?
No, there is no any evidence that Clobetamos is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Clobetamos will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Clobetamos is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Clobetamos cannot treat any kind of mental disorder.
Interaction between Food and Clobetamos
There isn't any research available on the side effects of taking Clobetamos with food.
Interaction between Alcohol and Clobetamos
Information about the interaction of Clobetamos and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
